go-v.orgdoi

d-Limonene: a bioactive food component from citrus and evidence for a potential role in breast cancer prevention and treatment

Jessica Anne Miller, Patricia A. Thompson, Iman A. Hakim, H.‐H. Sherry Chow, Cynthia A. Thomson · Oncology Reviews · 2011

  • DOI 10.4081/14
  • Publisher PAGEPress (Italy)
  • Type article
  • Issued 2011

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Oncology Reviews · PAGEPress (Italy) · article · 2011

Abstract

Although limited, observations from cell culture, animal, and epidemiological studies support the presence of anti-cancer properties in citrus peel and the primary bioactive food constituent, d-limonene. Early evidence from animal models suggests that when ingested, d-limonene exhibits a wide spectrum of biologic activity including chemotherapeutic and chemopreventive effects. In some of these early models, an analog of d-limonene, perillyl alcohol, demonstrated a more potent effect than d-limonene itself. Yet, when perillyl alcohol advanced to clinical trials, several trials were ended early due to doselimiting toxicities.

Alternatively, oral d-limonene administration in humans is well tolerated even at high doses supporting its investigation as a potential bioactive for cancer prevention. Though the exact mechanisms of action of d-limonene are unclear, immune modulation and antiproliferative effects are commonly reported. Here, we review the pre-clinical evidence for d-limonene’s anticancer mechanisms, bioavailability, and safety, as well as the evidence for anti-cancer effects in humans, focusing on studies relevant to its use in the prevention and treatment of breast cancer.

Open the resolved locator · 10.4081/14

Metadata licence: OpenAlex metadata (CC0)